Evidence map›Paper›PMID 42790294›Full record

ArticleJournal of geriatric oncology2026

Study protocol for a pilot randomized controlled trial of SONATA: A social network intervention for older adults with advanced cancer.

Meng-Jung Wen, Gretchen Roman, Sarah C Phillips, Soroush Mortaz Hedjri, Nancy Dukelow, Emily McGrain, Tanzi Love, Martha McGee, Ellen Mandwell, Becky Gravenstede and 8 more

Abstract read
In one paragraph

Article in Journal of geriatric oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Meng-Jung WenDepartment of Environmental Medicine and Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Gretchen RomanDepartment of Family Medicine, University of Rochester Medical Center, Rochester, New York, United States of America.
Sarah C PhillipsJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Soroush Mortaz HedjriJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Nancy DukelowPhysical Medicine and Rehabilitation, University of Rochester Medical Center, Rochester, New York, United States of America.
Emily McGrainHighland Hospital of Rochester, University of Rochester Medicine, Rochester, New York, United States of America.
Tanzi LoveDepartment of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Martha McGeeSOCARE Advisory Board, United States of America.
Ellen MandwellSOCARE Advisory Board, United States of America.
Becky GravenstedeJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Rachael G TylockJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Zahira A Quiñones TavárezDepartment of Environmental Medicine and Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Saahitya YadavJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Lauren N MitchellJames P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Suprya G MohileJames P. Wilmot Cancer Institute, Rochester, New York, United States of America; Division of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Ronald M EpsteinDepartment of Family Medicine, University of Rochester Medical Center, Rochester, New York, United States of America; James P. Wilmot Cancer Institute, Rochester, New York, United States of America; Department of Medicine (Palliative care), University of Rochester Medical Center, Rochester, New York, United States of America.
Reza Yousefi-NooraieDepartment of Environmental Medicine and Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America; James P. Wilmot Cancer Institute, Rochester, New York, United States of America.
Kah Poh LohJames P. Wilmot Cancer Institute, Rochester, New York, United States of America; Division of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America. Electronic address: kahpoh_loh@urmc.rochester.edu.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
Mentoring Patient-Oriented Research in Geriatric Hematology-OncologyK24AG102690 · NIA · UNIVERSITY OF ROCHESTER · PI Kah Poh Loh · 2026 to 2026
$206k
NCI NIH HHS R00 CA237744NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS K24 AG102690NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

introductionOlder adults with advanced cancer often experience functional, cognitive, and psychosocial challenges that can reduce patient activation and quality of life. They also rely heavily on family, friends, and other social network members for emotional, informational, and practical support. However, few geriatric oncology interventions explicitly target personal social networks as modifiable mechanisms to improve outcomes. The SOcial Networks to Activate Teamwork & Alliance (SONATA) intervention is a theory-informed, modular social network intervention designed to help older adults with advanced cancer identify, mobilize, and optimize support from their personal networks. Guided by the Self-Determination Theory, SONATA is designed to strengthen autonomy, perceived competence, relatedness, and social support, thereby improving patient activation and quality of life. MATERIAL AND

methodsThis pilot randomized controlled trial will evaluate the feasibility and preliminary efficacy of SONATA compared with enhanced usual care. We will recruit 70 older adults aged 65 years and older with advanced or likely incurable cancer from Wilmot Cancer Institute and affiliated community oncology practices. Participants will be randomized 1:1 to SONATA or enhanced usual care. Up to two social network members per patient may enroll in the intervention arm, although patients may participate without enrolled network members. SONATA is delivered by a coach across up to six flexible sessions and includes six components: goal setting, network diagnostics, network engagement, opportunity creation, skill building, and cycles of feedback. Enhanced usual care consists of publicly available National Cancer Institute educational materials. Assessments will occur at baseline, week 8, and week 16. The primary aim is to assess feasibility, acceptability, appropriateness, and perceived structure of SONATA. Secondary aims are to assess the preliminary efficacy of SONATA versus enhanced usual care for improving patient quality of life and activation. Quantitative analyses will estimate between-group differences; qualitative interviews and egocentric network analyses will inform intervention refinement. DISCUSSION: This pilot trial will generate essential feasibility data and preliminary signals of efficacy for a network-informed supportive care intervention for older adults with advanced cancer. Findings will guide refinement of SONATA and inform the design of a future fully powered randomized trial.

Indexed as

Advanced cancerGeriatric oncologyPatient activationQuality of lifeSocial network

Identifiers

PMID42790294
PMCPMC13679898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.